In the News

Accelerated Enrollment Solutions has introduced a new program to help biopharmaceutical companies maintain business continuity during the global COVID-19 pandemic.

Accelerated Enrollment Solutions and Science 37 are collaborating to recruit and enroll clinical trial participants who live beyond the geographic location of traditional research sites.

Mel Formica, global head, value and development consulting, Evidera, discusses the challenges regulators face as they seek to understand the acceptability of cutting-edge real-world data.

Kristopher Garibay, Eric Olson and Jonathon Salsbury of PPD® Laboratories GMP Lab discuss how the use of particle size distribution profiles by laser diffraction is a common analytical technique utilized across multiple industries.

Can investing in early formulation studies drive a new therapy successfully across the commercialization finish line?

Contract service organizations can offer biopharma companies early insight into dangers that may hinder a drug’s later development.

Patients are sharing their stories in an effort to educate other stakeholders, and the pharma industry is using that knowledge sharing to improve on messaging and patient interaction.

Patients are uniquely positioned to inform the understanding of the therapeutic context for drug development and evaluation.

In an effort to put patients at the center, pharmaceutical companies are starting to gather input from patients earlier in the clinical trial process.